Special considerations for conducting clinical performance studies for companion diagnostics under the European IVDD and IVDR
An amendment to Australia's therapeutic goods act 1989 calls for the creation of a unique device identification (UDI) system for medical devices.
New guidance from the US Food and Drug Administration explains a phased transition plan for medical devices currently covered by agency enforcement policies devised to address the COVID-19 public health emergency.
The Norwegian medicines agency (NoMA) has confirmed that, in order to be marketed in Norway, medical devices must include labeling and instructions for use (IFUs) in the Norwegian language.
The European medical devices regulation (MDR) requires manufacturers to establish clinical development plans (CDP). Learn more about EU MDR requirements at Emergo by UL.
In Brazil, a new ordinance was published by the National Institute of Metrology, Standardization and Industrial Quality (INMETRO), providing updated conformity assessment standards and documentation requirements.
The main reason for an economic operator to register in Eudamed has to do with the Single Registration Number (SRN).
The participating regulators in the medical device single audit program (MDSAP) issued a new guidance documents that is consolidated from two existing documents and expanded with additional annexes.
The US Food and Drug Administration plans a final rule for De Novo medical device classification as well as a proposed rule for closer harmonization to ISO 13485:2016 quality management system requirements for later in 2020.
Updated Japan MHLW requirements for MDSAP report submissions take effect in April 2022